Effect of Different Blood-Pressure-Lowering Regimens on the Blood Pressure Control among Hypertensive Patients Treated in Hospital Conditions

Table 5

Evaluation of efficacy of hypertension treatment in hospital environment according to the most common pharmacotherapy regimens.

Pharmacotherapy regimen	Number of patients on the pharmacotherapy regimen	Blood pressure measurement upon admission to the hospital		Blood pressure measurement upon discharge from the hospital		Blood pressure control (<130/80 mmHg) %
		Average systolic blood pressure values (mmHg, SEM ± SD)	Average diastolic blood pressure values (mmHg, SEM ± SD)	Average systolic blood pressure values (mmHg, SEM ± SD)	Average diastolic blood pressure values (mmHg, SEM ± SD)
β-blockers + ACEI (A)	19 (9.3%)	156.26 ± 12.04	94.37 ± 7.83	122.37 ± 9.06; $	73.63 ± 12.68; $	87.50; &; ^
Diuretics + ACEI (B)	19 (9.3%)	157.21 ± 9.46	92.68 ± 8.01	124.26 ± 9.42; $	76.79 ± 8.7; $	76.47; ^
β-blockers + diuretics + calcium channel antagonist (C)	54 (26.47%)	163.67 ± 14.12	94.61 ± 11.34	131.31 ± 12.30; #; $	79.43 ± 6.97; $	61.81; ^
ACEI + diuretics + ARBs (D)	25 (12.25%)	182.00 ± 23.06; #; &	103.32 ± 19.74; #; &	136.24 ± 16.25; #; $	82.80 ± 8.95; #; $	36.00

: level of statistical significance; was considered statistically significant. Statistically significant value in relation to group A for . #: statistically significant value in relation to group B for . &: statistically significant value in relation to group C for . ^: statistically significant value in relation to group D for . $: statistically significant value in relation to SBP reduction and DBP reduction among antihypertensive class combinations.